Global Metabolic Biomarker Testing Market Research Report 2023

Report ID: 1988646 | Published Date: Jan 2025 | No. of Page: 85 | Base Year: 2024 | Rating: 4.4 | Webstory: Check our Web story
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Technology
        1.2.1 Global Metabolic Biomarker Testing Market Size Growth Rate by Technology: 2017 VS 2021 VS 2028
        1.2.2 Separation Techniques
        1.2.3 Detection Techniques
        1.2.4 Others
    1.3 Market by Application
        1.3.1 Global Metabolic Biomarker Testing Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Drug Discovery
        1.3.3 Nutrigenomics
        1.3.4 Toxicology Testing
        1.3.5 Personalized Medicine
        1.3.6 Functional Genomics
        1.3.7 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Metabolic Biomarker Testing Market Perspective (2017-2028)
    2.2 Metabolic Biomarker Testing Growth Trends by Region
        2.2.1 Metabolic Biomarker Testing Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Metabolic Biomarker Testing Historic Market Size by Region (2017-2022)
        2.2.3 Metabolic Biomarker Testing Forecasted Market Size by Region (2023-2028)
    2.3 Metabolic Biomarker Testing Market Dynamics
        2.3.1 Metabolic Biomarker Testing Industry Trends
        2.3.2 Metabolic Biomarker Testing Market Drivers
        2.3.3 Metabolic Biomarker Testing Market Challenges
        2.3.4 Metabolic Biomarker Testing Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Metabolic Biomarker Testing Players by Revenue
        3.1.1 Global Top Metabolic Biomarker Testing Players by Revenue (2017-2022)
        3.1.2 Global Metabolic Biomarker Testing Revenue Market Share by Players (2017-2022)
    3.2 Global Metabolic Biomarker Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Metabolic Biomarker Testing Revenue
    3.4 Global Metabolic Biomarker Testing Market Concentration Ratio
        3.4.1 Global Metabolic Biomarker Testing Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Metabolic Biomarker Testing Revenue in 2021
    3.5 Metabolic Biomarker Testing Key Players Head office and Area Served
    3.6 Key Players Metabolic Biomarker Testing Product Solution and Service
    3.7 Date of Enter into Metabolic Biomarker Testing Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Metabolic Biomarker Testing Breakdown Data by Technology
    4.1 Global Metabolic Biomarker Testing Historic Market Size by Technology (2017-2022)
    4.2 Global Metabolic Biomarker Testing Forecasted Market Size by Technology (2023-2028)
5 Metabolic Biomarker Testing Breakdown Data by Application
    5.1 Global Metabolic Biomarker Testing Historic Market Size by Application (2017-2022)
    5.2 Global Metabolic Biomarker Testing Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Metabolic Biomarker Testing Market Size (2017-2028)
    6.2 North America Metabolic Biomarker Testing Market Size by Country (2017-2022)
    6.3 North America Metabolic Biomarker Testing Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Metabolic Biomarker Testing Market Size (2017-2028)
    7.2 Europe Metabolic Biomarker Testing Market Size by Country (2017-2022)
    7.3 Europe Metabolic Biomarker Testing Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Metabolic Biomarker Testing Market Size (2017-2028)
    8.2 Asia-Pacific Metabolic Biomarker Testing Market Size by Country (2017-2022)
    8.3 Asia-Pacific Metabolic Biomarker Testing Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Metabolic Biomarker Testing Market Size (2017-2028)
    9.2 Latin America Metabolic Biomarker Testing Market Size by Country (2017-2022)
    9.3 Latin America Metabolic Biomarker Testing Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Metabolic Biomarker Testing Market Size (2017-2028)
    10.2 Middle East & Africa Metabolic Biomarker Testing Market Size by Country (2017-2022)
    10.3 Middle East & Africa Metabolic Biomarker Testing Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Agilent Technologies
        11.1.1 Agilent Technologies Company Detail
        11.1.2 Agilent Technologies Business Overview
        11.1.3 Agilent Technologies Metabolic Biomarker Testing Introduction
        11.1.4 Agilent Technologies Revenue in Metabolic Biomarker Testing Business (2017-2022)
        11.1.5 Agilent Technologies Recent Development
    11.2 Bio-Rad Laboratories
        11.2.1 Bio-Rad Laboratories Company Detail
        11.2.2 Bio-Rad Laboratories Business Overview
        11.2.3 Bio-Rad Laboratories Metabolic Biomarker Testing Introduction
        11.2.4 Bio-Rad Laboratories Revenue in Metabolic Biomarker Testing Business (2017-2022)
        11.2.5 Bio-Rad Laboratories Recent Development
    11.3 Bruker
        11.3.1 Bruker Company Detail
        11.3.2 Bruker Business Overview
        11.3.3 Bruker Metabolic Biomarker Testing Introduction
        11.3.4 Bruker Revenue in Metabolic Biomarker Testing Business (2017-2022)
        11.3.5 Bruker Recent Development
    11.4 Danaher
        11.4.1 Danaher Company Detail
        11.4.2 Danaher Business Overview
        11.4.3 Danaher Metabolic Biomarker Testing Introduction
        11.4.4 Danaher Revenue in Metabolic Biomarker Testing Business (2017-2022)
        11.4.5 Danaher Recent Development
    11.5 Waters Corporation
        11.5.1 Waters Corporation Company Detail
        11.5.2 Waters Corporation Business Overview
        11.5.3 Waters Corporation Metabolic Biomarker Testing Introduction
        11.5.4 Waters Corporation Revenue in Metabolic Biomarker Testing Business (2017-2022)
        11.5.5 Waters Corporation Recent Development
    11.6 Thermo Fisher Scientific
        11.6.1 Thermo Fisher Scientific Company Detail
        11.6.2 Thermo Fisher Scientific Business Overview
        11.6.3 Thermo Fisher Scientific Metabolic Biomarker Testing Introduction
        11.6.4 Thermo Fisher Scientific Revenue in Metabolic Biomarker Testing Business (2017-2022)
        11.6.5 Thermo Fisher Scientific Recent Development
    11.7 Biocrates Life Sciences
        11.7.1 Biocrates Life Sciences Company Detail
        11.7.2 Biocrates Life Sciences Business Overview
        11.7.3 Biocrates Life Sciences Metabolic Biomarker Testing Introduction
        11.7.4 Biocrates Life Sciences Revenue in Metabolic Biomarker Testing Business (2017-2022)
        11.7.5 Biocrates Life Sciences Recent Development
    11.8 Human Metabolome Technologies
        11.8.1 Human Metabolome Technologies Company Detail
        11.8.2 Human Metabolome Technologies Business Overview
        11.8.3 Human Metabolome Technologies Metabolic Biomarker Testing Introduction
        11.8.4 Human Metabolome Technologies Revenue in Metabolic Biomarker Testing Business (2017-2022)
        11.8.5 Human Metabolome Technologies Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Metabolic Biomarker Testing Market Size Growth Rate by Technology (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Separation Techniques
    Table 3. Key Players of Detection Techniques
    Table 4. Key Players of Others
    Table 5. Global Metabolic Biomarker Testing Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 6. Global Metabolic Biomarker Testing Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 7. Global Metabolic Biomarker Testing Market Size by Region (2017-2022) & (US$ Million)
    Table 8. Global Metabolic Biomarker Testing Market Share by Region (2017-2022)
    Table 9. Global Metabolic Biomarker Testing Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 10. Global Metabolic Biomarker Testing Market Share by Region (2023-2028)
    Table 11. Metabolic Biomarker Testing Market Trends
    Table 12. Metabolic Biomarker Testing Market Drivers
    Table 13. Metabolic Biomarker Testing Market Challenges
    Table 14. Metabolic Biomarker Testing Market Restraints
    Table 15. Global Metabolic Biomarker Testing Revenue by Players (2017-2022) & (US$ Million)
    Table 16. Global Metabolic Biomarker Testing Market Share by Players (2017-2022)
    Table 17. Global Top Metabolic Biomarker Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Metabolic Biomarker Testing as of 2021)
    Table 18. Ranking of Global Top Metabolic Biomarker Testing Companies by Revenue (US$ Million) in 2021
    Table 19. Global 5 Largest Players Market Share by Metabolic Biomarker Testing Revenue (CR5 and HHI) & (2017-2022)
    Table 20. Key Players Headquarters and Area Served
    Table 21. Key Players Metabolic Biomarker Testing Product Solution and Service
    Table 22. Date of Enter into Metabolic Biomarker Testing Market
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Metabolic Biomarker Testing Market Size by Technology (2017-2022) & (US$ Million)
    Table 25. Global Metabolic Biomarker Testing Revenue Market Share by Technology (2017-2022)
    Table 26. Global Metabolic Biomarker Testing Forecasted Market Size by Technology (2023-2028) & (US$ Million)
    Table 27. Global Metabolic Biomarker Testing Revenue Market Share by Technology (2023-2028)
    Table 28. Global Metabolic Biomarker Testing Market Size by Application (2017-2022) & (US$ Million)
    Table 29. Global Metabolic Biomarker Testing Revenue Market Share by Application (2017-2022)
    Table 30. Global Metabolic Biomarker Testing Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 31. Global Metabolic Biomarker Testing Revenue Market Share by Application (2023-2028)
    Table 32. North America Metabolic Biomarker Testing Market Size by Country (2017-2022) & (US$ Million)
    Table 33. North America Metabolic Biomarker Testing Market Size by Country (2023-2028) & (US$ Million)
    Table 34. Europe Metabolic Biomarker Testing Market Size by Country (2017-2022) & (US$ Million)
    Table 35. Europe Metabolic Biomarker Testing Market Size by Country (2023-2028) & (US$ Million)
    Table 36. Asia-Pacific Metabolic Biomarker Testing Market Size by Region (2017-2022) & (US$ Million)
    Table 37. Asia-Pacific Metabolic Biomarker Testing Market Size by Region (2023-2028) & (US$ Million)
    Table 38. Latin America Metabolic Biomarker Testing Market Size by Country (2017-2022) & (US$ Million)
    Table 39. Latin America Metabolic Biomarker Testing Market Size by Country (2023-2028) & (US$ Million)
    Table 40. Middle East & Africa Metabolic Biomarker Testing Market Size by Country (2017-2022) & (US$ Million)
    Table 41. Middle East & Africa Metabolic Biomarker Testing Market Size by Country (2023-2028) & (US$ Million)
    Table 42. Agilent Technologies Company Detail
    Table 43. Agilent Technologies Business Overview
    Table 44. Agilent Technologies Metabolic Biomarker Testing Product
    Table 45. Agilent Technologies Revenue in Metabolic Biomarker Testing Business (2017-2022) & (US$ Million)
    Table 46. Agilent Technologies Recent Development
    Table 47. Bio-Rad Laboratories Company Detail
    Table 48. Bio-Rad Laboratories Business Overview
    Table 49. Bio-Rad Laboratories Metabolic Biomarker Testing Product
    Table 50. Bio-Rad Laboratories Revenue in Metabolic Biomarker Testing Business (2017-2022) & (US$ Million)
    Table 51. Bio-Rad Laboratories Recent Development
    Table 52. Bruker Company Detail
    Table 53. Bruker Business Overview
    Table 54. Bruker Metabolic Biomarker Testing Product
    Table 55. Bruker Revenue in Metabolic Biomarker Testing Business (2017-2022) & (US$ Million)
    Table 56. Bruker Recent Development
    Table 57. Danaher Company Detail
    Table 58. Danaher Business Overview
    Table 59. Danaher Metabolic Biomarker Testing Product
    Table 60. Danaher Revenue in Metabolic Biomarker Testing Business (2017-2022) & (US$ Million)
    Table 61. Danaher Recent Development
    Table 62. Waters Corporation Company Detail
    Table 63. Waters Corporation Business Overview
    Table 64. Waters Corporation Metabolic Biomarker Testing Product
    Table 65. Waters Corporation Revenue in Metabolic Biomarker Testing Business (2017-2022) & (US$ Million)
    Table 66. Waters Corporation Recent Development
    Table 67. Thermo Fisher Scientific Company Detail
    Table 68. Thermo Fisher Scientific Business Overview
    Table 69. Thermo Fisher Scientific Metabolic Biomarker Testing Product
    Table 70. Thermo Fisher Scientific Revenue in Metabolic Biomarker Testing Business (2017-2022) & (US$ Million)
    Table 71. Thermo Fisher Scientific Recent Development
    Table 72. Biocrates Life Sciences Company Detail
    Table 73. Biocrates Life Sciences Business Overview
    Table 74. Biocrates Life Sciences Metabolic Biomarker Testing Product
    Table 75. Biocrates Life Sciences Revenue in Metabolic Biomarker Testing Business (2017-2022) & (US$ Million)
    Table 76. Biocrates Life Sciences Recent Development
    Table 77. Human Metabolome Technologies Company Detail
    Table 78. Human Metabolome Technologies Business Overview
    Table 79. Human Metabolome Technologies Metabolic Biomarker Testing Product
    Table 80. Human Metabolome Technologies Revenue in Metabolic Biomarker Testing Business (2017-2022) & (US$ Million)
    Table 81. Human Metabolome Technologies Recent Development
    Table 82. Research Programs/Design for This Report
    Table 83. Key Data Information from Secondary Sources
    Table 84. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Metabolic Biomarker Testing Market Share by Technology: 2021 VS 2028
    Figure 2. Separation Techniques Features
    Figure 3. Detection Techniques Features
    Figure 4. Others Features
    Figure 5. Global Metabolic Biomarker Testing Market Share by Application in 2021 & 2028
    Figure 6. Drug Discovery Case Studies
    Figure 7. Nutrigenomics Case Studies
    Figure 8. Toxicology Testing Case Studies
    Figure 9. Personalized Medicine Case Studies
    Figure 10. Functional Genomics Case Studies
    Figure 11. Others Case Studies
    Figure 12. Metabolic Biomarker Testing Report Years Considered
    Figure 13. Global Metabolic Biomarker Testing Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 14. Global Metabolic Biomarker Testing Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 15. Global Metabolic Biomarker Testing Market Share by Region: 2021 VS 2028
    Figure 16. Global Metabolic Biomarker Testing Market Share by Players in 2021
    Figure 17. Global Top Metabolic Biomarker Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Metabolic Biomarker Testing as of 2021)
    Figure 18. The Top 10 and 5 Players Market Share by Metabolic Biomarker Testing Revenue in 2021
    Figure 19. North America Metabolic Biomarker Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. North America Metabolic Biomarker Testing Market Share by Country (2017-2028)
    Figure 21. United States Metabolic Biomarker Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. Canada Metabolic Biomarker Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. Europe Metabolic Biomarker Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. Europe Metabolic Biomarker Testing Market Share by Country (2017-2028)
    Figure 25. Germany Metabolic Biomarker Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. France Metabolic Biomarker Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. U.K. Metabolic Biomarker Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Italy Metabolic Biomarker Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Russia Metabolic Biomarker Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Nordic Countries Metabolic Biomarker Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Asia-Pacific Metabolic Biomarker Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Asia-Pacific Metabolic Biomarker Testing Market Share by Region (2017-2028)
    Figure 33. China Metabolic Biomarker Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Japan Metabolic Biomarker Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. South Korea Metabolic Biomarker Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Southeast Asia Metabolic Biomarker Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. India Metabolic Biomarker Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Australia Metabolic Biomarker Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Latin America Metabolic Biomarker Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Latin America Metabolic Biomarker Testing Market Share by Country (2017-2028)
    Figure 41. Mexico Metabolic Biomarker Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Brazil Metabolic Biomarker Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Middle East & Africa Metabolic Biomarker Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. Middle East & Africa Metabolic Biomarker Testing Market Share by Country (2017-2028)
    Figure 45. Turkey Metabolic Biomarker Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 46. Saudi Arabia Metabolic Biomarker Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 47. Agilent Technologies Revenue Growth Rate in Metabolic Biomarker Testing Business (2017-2022)
    Figure 48. Bio-Rad Laboratories Revenue Growth Rate in Metabolic Biomarker Testing Business (2017-2022)
    Figure 49. Bruker Revenue Growth Rate in Metabolic Biomarker Testing Business (2017-2022)
    Figure 50. Danaher Revenue Growth Rate in Metabolic Biomarker Testing Business (2017-2022)
    Figure 51. Waters Corporation Revenue Growth Rate in Metabolic Biomarker Testing Business (2017-2022)
    Figure 52. Thermo Fisher Scientific Revenue Growth Rate in Metabolic Biomarker Testing Business (2017-2022)
    Figure 53. Biocrates Life Sciences Revenue Growth Rate in Metabolic Biomarker Testing Business (2017-2022)
    Figure 54. Human Metabolome Technologies Revenue Growth Rate in Metabolic Biomarker Testing Business (2017-2022)
    Figure 55. Bottom-up and Top-down Approaches for This Report
    Figure 56. Data Triangulation
    Figure 57. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Agilent Technologies
Bio-Rad Laboratories
Bruker
Danaher
Waters Corporation
Thermo Fisher Scientific
Biocrates Life Sciences
Human Metabolome Technologies
Frequently Asked Questions
Metabolic Biomarker Testing report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Metabolic Biomarker Testing report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Metabolic Biomarker Testing report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

mHealth Applications

mHealth Applications market is segmented by players, region (country), by Type and by Application ... Read More

M-Health Device

The research report includes specific segments by region (country), by manufacturers, by Type and ... Read More